Skip to main content

S32 — Portfolio, Page 3

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

101
Companies
$6.4B
Total invested
$63.7M
Avg. check
42
Industries
Artificial Intelligence (AI) 11Biotechnology 11Health Care 9Medical 6Therapeutics 6Information Technology 5+36 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 4972 of 101
Gretel
October 2021

Gretel is a multimodal synthetic data platform that leverages advanced generative AI and privacy-enhancing technologies.

Artificial Intelligence (AI) · San Diego$52.2M Series B
Nested Therapeutics
October 2022

Nested Therapeutics aims to advance precision oncology medicine by finding new driver mutations.

Biotechnology · Cambridge$90.0M Series A
Sunbird Bio
October 2024

Sunbird Bio is a diagnostics platform developer that aims to give molecular diagnostics with faster outcomes.

Biotechnology · Singapore$14.0M Venture - Series Unknown
Stairwell
October 2022

Stairwell is a cybersecurity company that offers an Automated Threat Detection and Response platform that attackers can’t detect or evade.

Cyber Security · Mountain View$45.0M Series B
Outtake
January 2026

Outtake is a digital trust platform automating threat classification, detection, and response to enhance enterprise cybersecurity measures.

Artificial Intelligence (AI) · Brooklyn$40.0M Series B
Dave
January 2026

Dave is a banking app that offers customers banking, financial insights, overdraft protection, and building credit products.

Banking · Los AngelesUndisclosed
Celularity
December 2025

Celularity is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies.

Biotechnology · Florham Park$10.0M Post Ipo Debt
SandboxAQ
December 2025

SandboxAQ develops AI and quantum technology solutions that enhance biopharma, cybersecurity, and materials science.

Artificial Intelligence (AI) · Palo AltoPrivate Equity
Aspen Neuroscience
November 2025

Aspen Neuroscience is a biotechnology company that specializes in personalized cell therapies and autologous regenerative medicine.

Biotechnology · San Diego$115.0M Series C
Beacon Biosignals
November 2025

Beacon Biosignals is a neurotechnology company that brings precision neuroscience into clinical trials and treatments.

Artificial Intelligence (AI) · Boston$86.0M Series B
Octave
October 2025

Octave is a precision care company that provides diagnostic tools and care solutions for neurodegenerative diseases.

Biotechnology · Menlo ParkGrant
Phaidra
October 2025

Phaidra provides AI and ML solutions to accelerate performance in large-scale industries.

Artificial Intelligence (AI) · Seattle$50.0M Series B
Sola Security
September 2025

Sola Security provides a self-serve cybersecurity platform that enables organizations to build, customize, and manage security tools.

Artificial Intelligence (AI) · Tel Aviv-jaffa$35.0M Series A
Owl AI
June 2025

Owl AI is a sports technology company that uses artificial intelligence to improve performance analytics and decision-making in sports.

Analytics · San Francisco$11.0M Seed
Inductive Bio
May 2025

Inductive Bio provides the information, machine learning, tools, and know-how required to resolve ADMET issues.

Biotechnology · San Francisco$25.0M Series A
Arbor Biotechnologies
March 2025

Arbor Biotechnologies is a biotechnology company specializing in next-generation gene editing therapeutics to treat genetic diseases.

Artificial Intelligence (AI) · Cambridge$73.9M Series C
Network Bio
February 2025

Network Bio's biomedical data for AI-enabled precision medicine

Artificial Intelligence (AI) · New York$17.0M Seed
Meatable
November 2024

Meatable is a food production company that produces guilt-free meat.

Food and Beverage · LeidenSeries Unknown
Alector
November 2024

Alector is combining state-of-the-art antibody technology and recent discoveries in neuroimmunology and human genetics to develop novel.

Biotechnology · San Francisco$50.0M Post Ipo Debt
TollBit
October 2024

TollBit is a content monetization platform that allows AI bots and data scrapers to pay for content instead of scraping data from websites.

Artificial Intelligence (AI) · New York$24.0M Series A
Nusano
October 2024

Nusano is a physics firm that produces radioisotopes, tiny tracers doctors use to diagnose and cure cancer and other ailments.

Biotechnology · Valencia$115.0M Series C
Relay Therapeutics
September 2024

Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.

Biotechnology · Cambridge$200.0M Post Ipo Equity
Ema
July 2024

Ema uses AI-powered agents to automate tasks in HR, customer support, and data management, making enterprise workflows more efficient.

Artificial Intelligence (AI) · Mountain View$36.0M Series A
Autobahn Therapeutics
July 2024

Clinical stage biotechnology company developing restorative treatments for people affected by neuropsychiatric & neuroimmunologic disorders

Biotechnology · San Diego$100.0M Series C

Where S32 invests

Artificial Intelligence (AI)11
Biotechnology11
Health Care9
Medical6
Therapeutics6
Information Technology5

About S32's portfolio

How many companies has S32 invested in?

S32 has invested in 101 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does S32 invest in?

S32's top investment sectors include Artificial Intelligence (AI), Biotechnology, Health Care, Medical, Therapeutics. The firm invests across 42 different industry categories.

What is S32's largest investment?

Among tracked funding rounds, Relay Therapeutics received $200.0M in a Post Ipo Equity round. S32's total known invested capital is $6.4B.

What is the average investment size for S32?

S32's average investment size is $63.7M across its portfolio of 101 companies.

What are S32's most recent investments?

Recent S32 portfolio additions include Gretel, Nested Therapeutics, Sunbird Bio, Stairwell, Outtake. These companies were founded in 2020 or later.

Reach the founders behind these 101 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →